Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000258073 encodes a **pseudogene** related to the small nuclear ribonucleoprotein D2 polypeptide 16.5kDa (SNRPD2)[1]. The functional SNRPD2 gene product is a core component of the spliceosomal small nuclear ribonucleoproteins, which are essential for pre-mRNA splicing[3][5][7]. However, pseudogenes like ENSG00000258073 do not encode a functional protein and are generally considered transcriptionally or translationally inactive. There is no evidence that this pseudogene produces a protein, plays a direct biological function, or is implicated in disease, biomarker use, or drug targeting[1][5]. If your interest is the functional SNRPD2 gene/protein (Ensembl: ENSG00000125743), that is a genuine molecular target but unrelated to ENSG00000258073, which is a non-functional pseudogene. Summary: ENSG00000258073 is not a therapeutic target, not a functional gene, and is biologically and clinically irrelevant as a direct drug target or biomarker[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nuclear ribonucleoprotein D2 polypeptide 16.5kDa pseudogene.